CMS: Small, rural practices can ‘soon’ apply for $100M in technical MACRA assistance

Seeking to ease the fears for small and rural practices of being penalized under the new Merit-based Incentive Payment System (MIPS), CMS plans to soon release its request for proposals for the $100 million in technical assistance provided for those practices in 2015’s Medicare Access and CHIP Reauthorization Act (MACRA).

Speaking at an Alliance for Health Reform event May 20, CMS’ clinical quality director, Kate Goodrich, said it will be taking requests for the funding “relatively soon,” according to POLITICO.

CMS’ own data in the proposed MACRA rule said clinicians in groups of 24 or less would be penalized as underperforming under MIPS beginning in 2019, when penalties would be capped as high or low as 4 percent of Medicare fee-for-service revenue. The smaller the practice, the higher the chances were for negative adjustment: 59.4 percent for practices of 10-24 clinicians, 69.9 percent for 2-9 clinicians, and 87 percent for solo practices.

Since then, CMS has focused on making smaller practices less frightened by the transition. CMS’ acting director Andy Slavitt testified at a congressional hearing that the agency based its estimates on 2014 Medicare incentive programs, which may not reflect how physicians will respond to MIPS.

“Our data shows that physicians in small and solo practices can do just as well and actually do just as well as physicians in practices that are larger,” Slavitt said.

CMS has also released a fact sheet outlining the “flexibilities” for small practices under MACRA, including excluding clinicians and groups with less than or equal to $10,000 in Medicare charges and below 100 Medicare patients from MIPS payment adjustment. It also allows for solo and small practices to join “virtual groups” for the purposes of MIPS reporting. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.